Corporate Banner
Satellite Banner
Scientific Communities
Become a Member | Sign in
Home>News>This Article

AB SCIEX Announces New Version of Analyst Software

Published: Friday, June 14, 2013
Last Updated: Friday, June 14, 2013
Bookmark and Share
Windows 7-compatible software to control full suite of AB SCIEX triple quadrupoles and QTRAP® systems.

AB SCIEX has announced a new version of Analyst® Software that joins all of the triple quadrupoles and QTRAP® systems in the company’s industry-leading portfolio of LC/MS/MS instruments, including add-on capabilities such as SelexION, which provides a new level of selectivity for analysis of compounds.

The new software package brings all of the benefits of the evolution of Analyst Software - one of the most widely used mass spectrometry software platforms in the pharmaceutical industry - into a singular version that will enable lab managers to validate one piece of software for all instruments. This is expected to increase efficiency and lower costs for pharmaceutical companies.

To remain competitive and productive, laboratories conducting regulated bioanalysis upgrade their instrumentation on a regular basis.

Every time a new instrument is installed in a regulated laboratory, a new validation process is required.

Having different versions of software for different triple quadrupole and ion trap instruments validated at different times adds complexity, which AB SCIEX is addressing with this software launch.

By standardizing on the new 64-bit Windows 7, 32-bit Windows 7 and 32-bit XP-compatible version of Analyst Software, lab managers will now be in control of when their validation cycles occur.

Analyst Software v1.6.2 also future-proofs a laboratory, simplifying the process of bringing a new instrument in-house.

A lab can more easily adopt, for example, the highest sensitivity instrument on the market, the recently-released AB SCIEX 6500 System, for quantitation while using the same version of software to manage the older generation TripleQuad 5500 and 4000 systems, which are workhorse instruments known for robustness and reliability.

“We work closely with many of the major pharmaceutical companies to ensure that we evolve our software to meet their needs for greater efficiency and less complexity,” said Joe Fox, Senior Director of the Pharma Business Unit at AB SCIEX.

Fox continued, “The new Analyst Software is the first version to marry all of our triple quadrupoles and trap instruments on one software platform. Early feedback from customers, especially those interested in the 6500 series, is that this version of Analyst Software is going to make life easier for them going forward.”

Analyst Software meets the requirements of regulated lab environments with enhanced security, electronic signatures and field-tested compliant components as well as customizable settings and automated network acquisition capabilities.

The administration console provides multi-instrument project-wide security from a single computer. In addition, the software’s audit map allows each laboratory to configure the audit trail based on specific needs, preventing unnecessary or redundant event capture.

For those laboratories that are interested in assistance to facilitate the validation process, AB SCIEX offers Compliance and Validation Services to meet the most stringent requirements of the pharmaceutical industry.

This service offering provides a range of comprehensive validation and qualifications services, including software validation, along with HPLC IQ-OQ,MS IQ-OQ, and LC-MS PQ - a system function test that confirms performance of the MS, LC, and software together.

The company draws from its rich heritage of working with pharmaceutical companies and regulatory agencies accustomed to Analyst Software.

AB SCIEX was the first LC/MS provider to be 21 CFR Part 11 compliant more than a decade ago and has had a long-established leadership position in small molecule quantitation for regulated bioanalytical labs.

Analyst Software v1.6.2 also offers added benefits for laboratories engaged in food and environmental testing, forensic toxicology screening and clinical research applications.

The new Analyst software provides significant improvements to the Scheduled MRM™ Algorithm - renamed ‘Scheduled MRM™ Pro’ - enabling our users to have more control over their data acquisition parameters to significantly improve the quality of their data, particularly for quantitation of low-level compounds and when using unique scan functions on QTRAP® systems.

Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,500+ scientific posters on ePosters
  • More Than 5,100+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Collaboration to Develop Cannabis Testing Standards
SCIEX workflow solution enables cannabis labs to ensure product safety with robust, cost-effective analytical methods to facilitate routine testing.
Tuesday, September 13, 2016
SCIEX Works with the Francis Crick Institute and the University of Cambridge
New proteomic study to develop advanced resource for precision medicine research by using Microflow SWATH® Acquisition for HT industrialized proteomics.
Wednesday, June 29, 2016
Solutions for Biotherapeutic Characterization
Innovation to speed the routine.
Friday, June 17, 2016
SCIEX, QPS Holdings Collaborate
Agreement aims to advance the hybrid LBA-LCMS workflow for biologics quantification.
Wednesday, April 06, 2016
SCIEX, Children's Medical Research Institute Collaborate
SCIEX industrialized proteomics solutions, using SWATH® Acquisition-based workflows and powered by the OneOmics™ Project, will enable large scale proteome studies to advance cancer research.
Thursday, February 11, 2016
SCIEX, A*STAR’s BTI Launch Collaboration
Agreement aims to boost innovation of protein drugs that target new diseases and are safer for patients.
Wednesday, January 27, 2016
SCIEX, Pressure BioSciences Partner
SCIEX and Pressure BioSciences to offer complete solution for next-generation proteomics, to increase the reproducibility and depth of proteomic analysis.
Wednesday, January 13, 2016
SCIEX, University of Manchester Partner
SWATH® Acquisition-based next-generation proteomics technology promises to make industrial proteomics a reality.
Thursday, October 29, 2015
SCIEX Partners with the Paulovich Lab at Fred Hutchinson Cancer Research Center
Collaboration targets research reproducibility crisis with highly validated multiplex quantitation assays.
Wednesday, September 23, 2015
SCIEX and New Objective Announce Partnership
New nanospray sources to offer maximum sensitivity and robustness for NanoLC-MS.
Tuesday, June 02, 2015
SCIEX and New Objective Partner
Partnership will provide advanced nanospray ionization technologies for next-generation proteomics.
Tuesday, May 26, 2015
SCIEX and Hepregen Announce Co-Marketing Agreement
Alliance establishes SCIEX and Hepregen as a one-stop solution provider for drug metabolism investigators.
Friday, May 22, 2015
Sciex, Hepregen Team up on Metabolite Identification Offering
This recently announced collaboration aims to provide practical solutions for drug metabolism researchers.
Thursday, May 21, 2015
Dr. Gyula Vigh wins Arnold O. Beckman Award
SCIEX sponsored award recognizes outstanding contributions to the field of electrodriven separation techniques.
Thursday, May 07, 2015
SCIEX and Mass Consortium Corporation Announce Exclusive Reseller Agreement
SCIEX to provide customers with XCMSplus software solution for simplified and accelerated metabolomics workflows.
Tuesday, March 31, 2015
Scientific News
Integrated Omics Analysis
Studying multi-omics promises to give a more holistic picture of the organism and its place in its ecosystem, however despite the complexities involved those within the field are optimistic.
Unravelling the Role of Key Genes and DNA Methylation in Blood Cell Malignancies
Researchers from the University of Nebraska Medical Center have demonstrated the role of Dnmt3a in safeguarding normal haematopoiesis.
Salford Lung Study - The First Real World Clinical Trial
In this podcast, we learn about the Salford Lung Study and its potential to revolutionize the way we assess new drugs and treatments around the world.
Point of Care Diagnostics - A Cautious Revolution
Advances in molecular biology, coupled with the miniaturization and improved sensitivity of assays and devices in general, have enabled a new wave of point-of-care (POC) or “bedside” diagnostics.
Mass Spec Technology Drives Innovation Across the Biopharma Workflow
With greater resolving power, analytical speed, and accuracy, new mass spectrometry technology and techniques are infiltrating the biopharmaceuticals workflow.
Structure of Primary Cannabinoid Receptor is Revealed
The findings provide key insights into how natural and synthetic cannabinoids including tetrahydrocannabinol —a primary chemical in marijuana—bind at the CB1 receptor to produce their effects.
Illumina Contributes to ClinVar Database
The contribution includes variants of all classifications, from pathogenic to benign, identified during interpretation of whole genome sequences generated in the CLIA-certified, CAP-accredited Illumina Clinical Services Laboratory.
Overlooked Molecules Could Revolutionise our Understanding of the Immune System
Researchers have discovered that around one third of all the epitopes displayed for scanning by the immune system are a type known as ‘spliced’ epitopes.
Study Finds Key Regulator in Pulmonary Fibrosis
Researchers identify an enzyme that could open the way to therpies for chronic fatal lung disease.
Signaling Pathway Could Be Key to Improved Osteoporosis Treatment
Inhibition of SIK2 enzyme both stimulates bone formation and reduces bone breakdown in animal model.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,100+ scientific videos